Peng Jin, Ph.D.

Dr. Jin was born and raised in China. He received his doctorate in biomedical science from Seoul National University, South Korea, in 2018. During his doctoral research, he developed expertise studying how astrocyte-derived CCL20 reinforces hypoxic responses in glioblastoma. In his postdoctoral research at University of California, San Francisco, he studied hyper-mutated prostate cancer evolution via organoids, cell lines and mouse models.

Currently, his research focuses on elucidating important molecular players involved in brain tumor invasion and migration. He is also interested in developing new and more effective treatments for Glioblastoma via immunotherapy.

View Dr. Jin's publications at Google Scholar.